Adjuvant Wilms’ tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium
Van Genechten, Toon, De Laere, Maxime, Van den Bossche, Jolien, Stein, Barbara, De Rycke, kim, Deschepper, Caroline, Hazes, Katja, Peeters, Renke, Couttenye, Marie-Madeleine, Van De Walle, Katrien, Roelant, Ella, Maes, Sabine, Vanden Bossche, Stephanie, Dekeyzer, Sven, Huizing, Manon, Caluwaert, Kim, Nijs, Griet, Cools, Nathalie, Verlooy, Joris, Norga, Koen, Verhulst, Stijn, Anguille, Sebastien, Berneman, Zwi, Lion, Eva
Published in BMJ open (18.03.2024)
Published in BMJ open (18.03.2024)
Get full text
Journal Article